The Cooper Companies, Inc. $COO Shares Sold by Sustainable Growth Advisers LP

Sustainable Growth Advisers LP lessened its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 23.4% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,492,568 shares of the medical device company’s stock after selling 455,540 shares during the period. Cooper Companies comprises approximately 0.9% of Sustainable Growth Advisers LP’s holdings, making the stock its 25th biggest position. Sustainable Growth Advisers LP owned approximately 0.78% of Cooper Companies worth $84,375,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the business. Avalon Trust Co bought a new stake in Cooper Companies during the second quarter valued at approximately $25,000. SJS Investment Consulting Inc. raised its position in Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after acquiring an additional 187 shares during the period. Elevation Wealth Partners LLC raised its position in Cooper Companies by 1,136.4% in the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock worth $29,000 after acquiring an additional 375 shares during the period. Continuum Advisory LLC bought a new position in Cooper Companies in the second quarter worth approximately $30,000. Finally, J.Safra Asset Management Corp bought a new position in Cooper Companies in the second quarter worth approximately $32,000. Institutional investors own 24.39% of the company’s stock.

Insider Transactions at Cooper Companies

In other news, Director Paul Keel acquired 4,701 shares of Cooper Companies stock in a transaction dated Friday, September 11th. The stock was purchased at an average cost of $53.18 per share, with a total value of $249,999.18. Following the completion of the purchase, the director directly owned 4,701 shares in the company, valued at approximately $249,999.18. This trade represents a ? increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Walter Rosebrough, Jr. bought 3,000 shares of the stock in a transaction that occurred on Monday, September 14th. The shares were purchased at an average price of $54.29 per share, for a total transaction of $162,870.00. Following the purchase, the director owned 20,000 shares in the company, valued at $1,085,800. This represents a 17.65% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought a total of 34,701 shares of company stock valued at $1,880,039 over the last three months. Corporate insiders own 2.08% of the company’s stock.

Analyst Ratings Changes

COO has been the topic of several analyst reports. Zacks Research cut shares of Cooper Companies from a “hold” rating to a “strong sell” rating in a research note on Friday, September 11th. Bank of America restated a “neutral” rating and issued a $65.00 price objective (down from $80.00) on shares of Cooper Companies in a research note on Thursday, September 10th. Citigroup restated a “neutral” rating and issued a $60.00 price objective (down from $80.00) on shares of Cooper Companies in a research note on Thursday, September 10th. Needham & Company LLC decreased their target price on Cooper Companies from $86.00 to $73.00 and set a “buy” rating on the stock in a report on Thursday, September 10th. Finally, William Blair downgraded Cooper Companies from an “outperform” rating to a “market perform” rating in a research report on Thursday, September 10th. Four investment analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $68.60.

Cooper Companies Trading Up 4.6%

Shares of NASDAQ:COO opened at $57.40 on Friday. The stock has a 50 day moving average of $63.78 and a 200 day moving average of $66.20. The company has a market cap of $10.91 billion, a PE ratio of 19.59, a price-to-earnings-growth ratio of 2.23 and a beta of 0.83. The company has a current ratio of 1.22, a quick ratio of 0.73 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 12-month low of $51.01 and a 12-month high of $89.83.

Cooper Companies (NASDAQ:COO) last released its earnings results on Wednesday, September 9th. The medical device company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.12 by $0.03. Cooper Companies had a net margin of 13.46% and a return on equity of 10.90%. The company had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.10 billion. During the same quarter last year, the business earned $0.49 EPS. The firm’s revenue was up .5% compared to the same quarter last year. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. As a group, equities research analysts expect that The Cooper Companies, Inc. will post 4.53 EPS for the current year.

Cooper Companies declared that its Board of Directors has approved a stock buyback plan on Wednesday, September 9th that allows the company to buy back $3.00 billion in shares. This repurchase authorization allows the medical device company to purchase up to 22.7% of its shares through open market purchases. Stock repurchase plans are typically a sign that the company’s board believes its stock is undervalued.

About Cooper Companies

CooperCompanies (NASDAQ: COO) is a global medical device company focused on improving vision and advancing women’s health. Its operations are organized primarily through CooperVision and CooperSurgical, which develop, manufacture and distribute products for eye care, fertility and other areas of reproductive health.

CooperVision offers a broad range of contact lenses, including lenses for nearsightedness, farsightedness, astigmatism and presbyopia. Its portfolio includes daily disposable, reusable and specialty lenses, as well as products designed to address the progression of myopia in children and adolescents.